Web
|
Images
|
News
News Home
US
World
Business
Finance
Industry
Technology
Science
Media & Advertising
Politics/Law
Entertainment
Internet
Health
Sports
Culture
CANCER
Log In
London Cancer New Drugs Group Rapid Review: Lapatinib with capecitabine following
Have an interest in this Story?
Sign Up for Real-Time email updates
NHS NeLM
|
February 07, 2012
Source: London Cancer New Drugs Group Date published: 07/02/2012 11:22 Summary Lapatinib is licensed for the treatment of patients with breast cancer, whose tumours overexpress HER2 in combination with capecitabine for patients with advanced or metastatic disease with progression following prior the...
Read Full Article
Leave a Comment:
You must be logged in to leave a comment
Log in
|
Register
Most Read Cancer Articles
Holistic nutrition
- TheStar.com.my
Smoking bans are here to stay
- Parkersburg News
MIRACLE NOODLES on the HCG Diet Portland!
- Zimbio
Exercise 'crucial to older adult's fitness and health'
- Sify
The project Horn of Africa Emergency Health and Nutrition Project has changed to
- World Bank
Featured Members
Dr. Monte Hessler
Chiropractic care for Phoenix, Arizona
Healthcare General
Carolyn Katzin
President
Cancer
View more profiles
Access dozens of premium and subscriptions sites
Free!
Download now
.
Advertise
|
Build a News Circle
|
Get News Briefings
|
Congoo News Home
|
Get the Netpass
About Congoo
|
Terms
|
Privacy
|
Need Help?
|
Site Map
Copyright ©2012 Congoo.com. All Rights Reserved.